# Inhibrx Biosciences, Inc. (INBX) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$135M |
| 2024 | -$331M |
| 2023 | -$219M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2025-09-30 | -$34M |
| 2025-06-30 | -$27M |
| 2025-03-31 | -$43M |
| 2024-09-30 | -$47M |
| 2024-06-30 | -$161M |
| 2024-03-31 | -$74M |
| 2023-09-30 | -$46M |
| 2023-06-30 | -$41M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/INBX/operating-income)